Skip to main content
Blood Advances logoLink to Blood Advances
. 2022 Aug 1;6(15):4437–4438. doi: 10.1182/bloodadvances.2022008474

Etra A, Gergoudis S, Morales G, et al. Assessment of systemic and gastrointestinal tissue damage biomarkers for GVHD risk stratification. Blood Adv. 2022;6(12):3707-3715.

PMCID: PMC9636398  PMID: 35913751

Page 3710: Due to formatting errors, Table 2 does not correctly delineate the individual biomarker models from each other. “Single Biomarker Model” should show 5 individual biomarker models, not one 5-biomarker grouping. “Two Biomarker Model” should show six 2-biomarker models, not one 12-biomarker grouping. “Three Biomarker Model” should show four 3-biomarker models, not one 12-biomarker grouping.

Table 2.

Training cohort biomarker algorithms and their respective p values

graphic file with name fx1.gif

Also, “REG3” should read “REG3α.” The corrected Table 2 is shown below:

The errors have been corrected in the published article.


Articles from Blood Advances are provided here courtesy of The American Society of Hematology

RESOURCES